What Raising the Buprenorphine Cap Means for ASAM Members

5 (2 votes)

  • Register
    • Regular Member - Free!
    • Retired - Free!
    • Early Career Physician - Free!
    • Resident - Free!
    • Student - Free!
    • Associate - Free!
    • ASAM Staff - Free!
    • Non-Member - Free!
    • International Member - Free!
    • Emeritus Member - Free!
    • Provisional Member - Free!
    • Fellow Member - Free!
    • Honorary Member - Free!

WHAT: This one-hour webinar provides an overview of the qualifications, requirements and processes related to applying for and maintaining the higher patient limit, as well as specific implications for ASAM members. Importantly, the webinar addresses practice management issues such as documenting a diversion control plan, demonstrating adherence to evidence-based guidelines, and formalizing agreements with behavioral health service providers.

WHO: Physicians interested in applying for the higher limit, as well as their practice managers and care team.

WHY: Evaluate your qualifications for the limit increase and prepare for the application and reporting processes.

R. Corey Waller

MD, MS, DFASAM

R. Corey Waller, MD, MS, FACEP, DFASAM, is an addiction, pain and emergency medicine specialist. Dr. Waller earned his bachelor's degree in biology and his master's degree in neuromolecular biology at Southwest Texas State University in San Marcos, Texas. He earned his medical degree at University of Texas Medical School in San Antonio. Dr. Waller completed his emergency medicine residency at Thomas Jefferson University in Philadelphia. He is board certified and fellowship trained in addiction medicine.

No relevant financial relationships

Jinhee Lee

Senior Public Health Advisor, Division of Pharmacologic Therapies, Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration

CDR Jinhee Lee, PharmD, is a Senior Public Health Advisor in the Division of Pharmacologic Therapies, Center for Substance Abuse Treatment at the Substance Abuse and Mental Health Services Administration (SAMHSA). She is the co-lead for SAMSHA's Prescription Drug Abuse initiative and the project officer for two SAMHSA PDMP EHR cooperative agreement programs. She has also served as a core member of the Office of the National Coordinator for Health Information Technology's project to improve access to PDMP through Health Information Technology for the last few years.

Prior to joining SAMHSA, CDR Lee was a Senior Regulatory Review Officer at the FDA and also previously worked as a clinical pharmacist at the Washington Hospital Center. She earned her Bachelor of Science degree from the University of California, Los Angeles, Doctor of Pharmacy degree from the University of Illinois, ASHP Pharmacy Practice Residency at the Washington Hospital Center, and an Executive Fellowship in Patient Safety through the Virginia Commonwealth University.

Key:

Complete
Failed
Available
Locked
Webinar Recording
Open to view video.
Open to view video. Webinar recorded on August 3, 2016.